Technical Analysis for LIPO - Lipella Pharmaceuticals Inc.

Grade Last Price % Change Price Change
F 2.47 -1.00% -0.03
LIPO closed up 3.53 percent on Monday, January 30, 2023, on 3 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup -1.00%
Narrow Range Bar Range Contraction -1.00%
Inside Day Range Contraction -1.00%
Wide Bands Range Expansion -1.00%
Oversold Stochastic Weakness -1.00%
New 52 Week Closing Low Bearish 2.49%
Hot IPO Pullback Bullish Swing Setup 2.49%
Narrow Range Bar Range Contraction 2.49%
New 52 Week Closing Low Bearish 1.23%
Hot IPO Pullback Bullish Swing Setup 1.23%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Hot IPO Pullback Entry about 3 hours ago
Rose Above Previous Day's High about 3 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Rose Above Previous Day's High 5 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. We believe that this strategy combines many of the cost efficiencies and risk abatements derived from using existing generic drugs with potential patent protections for our proprietary formulations; this strategy allows us to expedite, protect, and monetize our product candidates. Additionally, we maintain a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists, believing that this focus can potentially help reduce the cost, time and risk associated with obtaining marketing approval.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Generic Drug Drug Therapy

Is LIPO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.72
52 Week Low 2.31
Average Volume 1,386,071
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 3.09
10-Day Moving Average 2.60
Average True Range 0.73
RSI 35.48
ADX 0.0
+DI 19.65
-DI 22.13
Chandelier Exit (Long, 3 ATRs) 5.54
Chandelier Exit (Short, 3 ATRs) 4.49
Upper Bollinger Bands 4.30
Lower Bollinger Band 1.88
Percent B (%b) 0.25
BandWidth 78.26
MACD Line -0.42
MACD Signal Line -0.30
MACD Histogram -0.1205
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.68
Resistance 3 (R3) 2.66 2.58 2.65
Resistance 2 (R2) 2.58 2.53 2.59 2.63
Resistance 1 (R1) 2.54 2.50 2.56 2.56 2.62
Pivot Point 2.46 2.46 2.47 2.47 2.46
Support 1 (S1) 2.42 2.41 2.44 2.44 2.37
Support 2 (S2) 2.34 2.38 2.35 2.36
Support 3 (S3) 2.30 2.34 2.35
Support 4 (S4) 2.32